Disclaimer: This is a simplified summary of a public company filing. See full disclaimer here.

XWELL, Inc.

CIK: 14104282 Annual ReportsLatest: 2025-04-28

10-K / April 28, 2025

Revenue:$33,897,000
Income:-$16,853,000

10-K / April 29, 2024

Revenue:$30,109,000
Income:-$28,029,000

10-K / April 28, 2025

Company Summary – XWELL, Inc.

Overview:
XWELL, Inc. is a Delaware corporation with its principal offices located at 254 West 31st Street, 11th Floor, New York, NY 10001. The company is publicly traded on the Nasdaq Stock Market LLC under the ticker symbol XWEL, and had approximately 5,261,024 shares of common stock outstanding as of April 25, 2025.


Core Business Activities

  • The company operates in the healthcare and wellness sector, focusing on consumer health products and services, with specific emphasis on branding, manufacturing, and global distribution of consumer goods.
  • Its operations include strategic investments, joint ventures, acquisitions, and divestitures in the health and wellness industry.

Employees

  • The company does not specify the total number of employees.
  • Executive team includes key officers such as Ezra T. Ernst (President & CEO), Ian Brown (Chief Financial Officer), among others.

Customers

  • The company does not specify the exact number of customers.

Financial Highlights

  • As of June 30, 2024, the market value of the company’s voting common stock held by non-affiliates was approximately $7.54 million, based on a closing stock price of $1.80.
  • Revenue, net income, and other financial data are not provided in the document.

Additional Details

  • The company is designated as a smaller reporting company and an emerging growth company (although it has elected not to extend the transition period under certain standards).
  • The company does not have any publicly registered securities other than its common stock on Nasdaq.
  • The company has no reported securities registered under Section 12(g) of the Securities Exchange Act.

Non-financial Information

  • The company has a formal Code of Conduct and Ethics, and maintains policies on insider trading and related party transactions.
  • It has a Board of Directors consisting of five members, with diverse backgrounds in finance, securities, branding, and healthcare.

Note:
This summary is based solely on the given 10-K/A filing, which focuses on corporate governance, executive details, and certain financial and ownership information. It does not include specific revenue, profit/loss figures, number of customers, or detailed operational metrics beyond what is provided.